Prosecution Insights
Last updated: October 25, 2026

COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Analysis

Council Of Scientific And Industrial Research An Indian Registered Body Incorpor has 1 pending office action in Biotechnology & Pharmaceuticals. The action is assigned to 1 examiner and 1 art unit, creating a single prosecution path.

ZINGARELLI, SANDRA is the busiest examiner, with 1 pending matter. The response can be directed toward the specific examination issues without coordinating across multiple active assignments.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (50%)
1
Medium (25%)
1
Easy (25%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (25%)
§112 only1 (25%)
Multi-statute (no §101)2 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
JACKSON, SHAWQUIA 1 78.0% -3.4%
SARANTAKOS, KAYLA ROSE 1 37.1% +49.7%
JONES-FOSTER, ERICA NICOLE 1 49.4% +44.0%
CHAO, ALLEN 1 60.0% +0.0%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18698473 DISINFECTION AND IN SITU FLOCCULATION-SOLIDIFICATION PROCESS FOR PATHOGENIC MEDICAL WASTE DISPOSAL SARANTAKOS, KAYLA ROSE —
18686652 PYRAZOLE AMIDE BASED COMPOUNDS AND USES AGAINST BREAST CANCER THEREOF CHAO, ALLEN —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18691945 A COMPOSITION FOR ANTI-BACTERIAL BIO-CELLULOSIC PATCHES USEFUL FOR TRANSDERMAL DRUG DELIVERY AND A PROCESS FOR THE PREPARATION THEREOF JONES-FOSTER, ERICA NICOLE 3d overdue
18698473 DISINFECTION AND IN SITU FLOCCULATION-SOLIDIFICATION PROCESS FOR PATHOGENIC MEDICAL WASTE DISPOSAL SARANTAKOS, KAYLA ROSE —

Top Art Units

Art UnitApps
1626 1
1799 1
1656 1
1622 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18723847 A PREPARATION OF QUINAZOLINEDIONES AND USE THEREOF JACKSON, SHAWQUIA 1626 §112 Final Rejection — Pending Jun 24, 2024
18698473 DISINFECTION AND IN SITU FLOCCULATION-SOLIDIFICATION PROCESS FOR PATHOGENIC MEDICAL WASTE DISPOSAL SARANTAKOS, KAYLA ROSE 1799 §102§103§112 Non-Final OA — Pending Apr 04, 2024
18691945 A COMPOSITION FOR ANTI-BACTERIAL BIO-CELLULOSIC PATCHES USEFUL FOR TRANSDERMAL DRUG DELIVERY AND A PROCESS FOR THE PREPARATION THEREOF JONES-FOSTER, ERICA NICOLE 1656 §103 Non-Final OA 3d overdue Pending Mar 14, 2024
18686652 PYRAZOLE AMIDE BASED COMPOUNDS AND USES AGAINST BREAST CANCER THEREOF CHAO, ALLEN 1622 §103§112 Non-Final OA — Pending Feb 26, 2024

Managing COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH have?

COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.

Which USPTO examiner handles the most COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH applications?

Shawquia Jackson has the most, with 1 of COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH's pending office actions.

What technology area are COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month